Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial. uri icon

authors

  • Butler, Christopher C
  • Breuer, Judith
  • Khoo, Saye
  • Petrou, Stavros
  • Hood, Kerenza
  • Nguyen-Van-Tam, Jonathan S
  • Patel, Mahendra G
  • Saville, Benjamin R
  • Marion, Joe
  • Ogburn, Emma
  • Allen, Julie
  • Hobbs, F D Richard
  • Rutter, Heather
  • Francis, Nick
  • Thomas, Nicholas P B
  • Evans, Philip
  • Dobson, Melissa
  • Madden, Tracie-Ann
  • Holmes, Jane
  • Harris, Victoria
  • Png, May Ee
  • Lown, Mark
  • Gbinigie, Oghenekome A
  • van Hecke, Oliver
  • Detry, Michelle A
  • Saunders, Christina T
  • Fitzgerald, Mark
  • Berry, Nicholas S
  • Mwandigha, Lazaro
  • Galal, Ushma
  • Mort, Sam
  • Jani, Bhautesh D
  • Hart, Nigel D
  • Rahman, Najib M
  • Ahmed, Haroon
  • Butler, Daniel
  • McKenna, Micheal
  • Chalk, Jem
  • Lavallee, Layla
  • Hadley, Elizabeth
  • Cureton, Lucy
  • Benysek, Magdalena
  • Andersson, Monique
  • Coates, Maria
  • Hayward, Gail
  • Barrett, Sarah
  • Bateman, Clare
  • Davies, Jennifer C
  • Raymundo-Wood, Ivy
  • Ustianowski, Andrew
  • Carson-Stevens, Andrew
  • Yu, Ly-Mee
  • Little, Paul
  • Richards, Duncan B
  • Dorward, Jienchi
  • Lowe, David M
  • Standing, Joseph F

publication date

  • January 1, 2022